Chronic Myeloid Leukemia (Ph+ CML)
Patient Support
The goal of therapy for Philadelphia chromosome-positive Ph+ CML is to stabilize blood counts and achieve and maintain hematological, cytogenetic, and molecular response.
- A complete hematological response means white blood cell, platelet, and red blood cell counts have returned to a normal range
- A complete cytogenetic response means that, using currently available tests, no cells with the Ph chromosome are found in the bone marrow sample or blood sample. A major cytogenetic response means that no more than 35% of the cells in the bone marrow sample or blood sample have the Ph chromosome
- A complete molecular response means that, using currently available tests, there is no Bcr-Abl protein found in the bone marrow sample or blood sample. A major molecular response means that the amount of Bcr-Abl protein found in the bone marrow sample or blood sample is very low
The more you know about treating Ph+ CML, the more you will be able to play an active role in your treatment. To learn more about treatment support available to you from CML Alliance™, please visit the Patient Support Program.
To learn and understand more about Ph+ CML and its treatment visit LivingWithCML.com.
